Indeed, miR-29a directly targets IRS1 3′UTR, thus repressing its expression; moreover, miR-29a is induced upon saturated fatty acid (palmitate) treatment, therefore contributing to the development of insulin resistance [99]. The gene discussed is IRS1; the disease is Insulin resistance.